Polaryx Therapeutics Announces the Appointment of Dr. Lisa Bollinger as Chief Medical Officer
PARAMUS, NJ, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- Polaryx Therapeutics, a late-stage clinical biotech company developing drugs for lysosomal storage disorders, today announces the appointment of Lisa L. Bollinger, M.D. as Chief …